Stay updated on Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial

Sign up to get notified when there's something new on the Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:49:04.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in the study details related to the effects of adding carfilzomib to the combination of pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma.
    Difference
    0.1%
    Check dated 2024-06-06T14:25:17.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The value 'Participation Criteria 6' has been updated to a detailed description of 'Participation Criteria' which now includes an explanation of eligibility criteria and examples such as a person's general health condition or prior treatments. Additionally, specific inclusion criteria for the study have been provided.
    Difference
    41%
    Check dated 2024-05-22T20:56:54.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1.0%
    Check dated 2024-04-30T22:52:21.000Z thumbnail image

Stay in the know with updates to Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Carfilzomib Pomalidomide Dexamethasone in MM Clinical Trial page.